SCHEMBL20355293

SCHEMBL20355293

CC(CCC(=N)N)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.47
SLC6A2 P23975 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
SLC6A4 P31645 2/20 0.47
MAOA P21397 1/20 0.47
SLC6A3 Q01959 1/20 0.47
CYP2A6 P11509 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
CYP2D6 P10635 1/20 0.44
TRPA1 O75762 2/20 0.43
EPHX1 P07099 2/20 0.41
IDO1 P14902 2/20 0.40
SLC18A2 Q05940 1/20 0.40
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28228765 0.82 EPHX1 (0.47) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL19956451 0.82 TAAR1 (0.47) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
Hydrochloric Acid SCHEMBL11250702 0.79 TRPA1 (0.44) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL757260 0.78 CPA3 (0.62) SLC6A3NPC1RAB9A
SCHEMBL3440803 0.78 CPA3 (0.62) SLC6A3NPC1RAB9A
SCHEMBL27878945 0.78 TRPA1 (0.46) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL13235780 0.76 ALDH1A1 (0.55) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL20208030 0.76 ALDH1A1 (0.55) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL13003087 0.75 TAAR1 (0.56) TAAR1SLC6A2SIGMAR1SLC6A4MAOA
SCHEMBL11990712 0.75 TAAR1 (0.56) TAAR1SLC6A2SIGMAR1SLC6A4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018122775-A1 HETEROARYL COMPOUNDS AND THEIR USE MINORYX THERAPEUTICS S.L. (ES) 2018-07-05 WO disclosed